The aim of this multicenter, randomized, controlled, open-label trial is to investigate the efficacy of early treatment with HFNO compared with SOT in preventing early deterioration of patients admitted to the ER because of acute hypoxemic respiratory failure.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
234
humidified and heated oxygen
oxygen delivery through Venturi mask
Early deterioration
occurrence of any of the following from randomization: respiratory worsening; respiratory acidosis; severe respiratory distress; start of non-invasive ventilation; necessity of endotracheal intubation; development of shock; death.
Time frame: 24 hours
Development of respiratory acidosis
arterial pH
Time frame: 2, 12 and 24 hours
Development of hypercapnia
arterial pCO2
Time frame: 2, 12 and 24 hours
Worsening hypoxemia
P/F ratio
Time frame: 2, 12 and 24 hours
Worsening respiratory distress
respiratory frequency
Time frame: 2, 12 and 24 hours
duration of any type of ventilatory support
hours of ventilatory support
Time frame: 90 days
rate of ICU admission
number of patients admitted to ICU
Time frame: 90 days
hospital length-of-stay
duration of hospitalization
Time frame: 30 days
in-hospital mortality
death during hospitalization
Time frame: 90 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
ICU length-of-stay
duration of ICU stay
Time frame: 90 days
ICU mortality
death in ICU
Time frame: 90 days
development of complications
composite outcome of septic shock, nosocomial pneumonia, cardiac arrhythmia, cardiac arrest, delirium
Time frame: 90 days
level of dyspnea
utilizing Borg scale
Time frame: 24 hours
patient comfort
utilizing visual analogue scale
Time frame: 24 hours
clinical setting after ED stabilization
type of ward admission
Time frame: 24 hours
standard vs asymmetrical high-flow nasal cannula
rate of early deterioration in the treatment group will be compared between patients treated with standard or asymmetrical high-flow nasal cannula
Time frame: 24 hours